News Headline Summary
EU says Johnson & Johnson (JNJ) and Novartis (NOVN VX) contracts delayed generic drugs
- Co.'s get EU antitrust objections.
- EU probings JNJ and NOVN VX contracts over Fentanyl painkiller.
Reaction details (10:49)
- Novartis shares are unmoved in reaction to the news; trades CHF 61.90 (-0.40%) last.
31 Jan 2013 - 10:45
Subscribe Now to RANsquawk
Click here for a 1 week free trial
RANsquawk provides audio news and commentary for over 15,000
professional traders and brokers worldwide. Services include:
Real-time audio coverage from 0630 to 2130 London time
Teams of analysts covering equities, fixed income, FX and energy markets
Real-time scrolling news service
Daily and weekly pre-market research and calendars
Intra-day market update videos
Daily technical analysis